How to Finance a Fertility Clinic Acquisition

From PE equity recaps to seller-carried notes, understand the capital structures driving IVF practice deals in the $2M–$5M revenue range.

Find Fertility Clinic Deals SBA Calculator →

Fertility clinics are not SBA-eligible due to healthcare restrictions on passive income and corporate practice of medicine structures. Buyers typically rely on private equity equity contributions, conventional bank debt, and seller financing layered through an MSO structure. With EBITDA multiples ranging from 5x to 9x, a disciplined capital stack is essential to achieving acceptable debt service coverage and protecting post-close operations.

Financing Options for Fertility Clinic Acquisitions

Private Equity Equity Contribution

$3M–$15M depending on platform size and deal structureTarget IRR of 20–30%; no fixed interest rate

PE-backed fertility platforms such as US Fertility or Inception Fertility contribute equity capital—typically 40–60% of purchase price—in exchange for majority ownership, often retaining the founding RE as a minority equity partner through a recapitalization.

Pros

Provides substantial non-debt capital reducing leverage and debt service pressure post-close
PE partner brings operational infrastructure, employer benefit contracts, and recruiting networks
Founding physician retains upside through rollover equity tied to EBITDA growth earnouts

Cons

×Founder loses majority control and must accept platform operating standards and reporting requirements
×PE exit timeline of 4–7 years may not align with physician's long-term practice vision
×Earnout targets tied to patient volume can create pressure that conflicts with clinical judgment

Conventional Bank or Healthcare Lender Term Loan

$2M–$8M based on 2.5x–4x EBITDA coveragePrime + 1.5–3.5%; typically 7.5–10.5% as of 2024

Specialty healthcare lenders such as Live Oak Bank, PNC Healthcare, or CIT provide senior secured term loans against clinic EBITDA, typically requiring strong IVF lab accreditation, SART membership, and multi-physician staffing to qualify.

Pros

Preserves buyer equity by leveraging clinic cash flow to fund a significant portion of purchase price
Structured amortization over 5–7 years with predictable monthly debt service obligations
Lenders experienced in healthcare understand MSO structures and physician employment agreement nuances

Cons

×Requires minimum $1.5M EBITDA and clean regulatory history; below-average SART rates may disqualify
×Covenants often require DSCR above 1.25x, limiting capital available for post-close lab upgrades
×Single-physician practices face heavy scrutiny; lenders may require key-man life insurance policies

Seller-Financed Note

$500K–$2M representing 10–20% of total deal value6–8% fixed; interest-only during transition period common

Founding RE carries 10–20% of purchase price as a subordinated promissory note, typically held 2–3 years, contingent on successful physician transition, patient retention thresholds, and regulatory license transferability post-close.

Pros

Signals seller confidence in practice performance and aligns incentives through the transition period
Reduces day-one cash requirement for buyer, improving post-close liquidity for lab capex
Negotiable terms allow contingencies tied to physician handoff milestones and patient retention rates

Cons

×Seller remains financially exposed post-close and may interfere with buyer operational decisions
×Note forgiveness disputes arise if patient volume declines due to market conditions beyond buyer control
×Subordinate position behind senior debt means seller note repayment is at risk if clinic underperforms

Sample Capital Stack

$6.5M (approximately 6.5x $1M EBITDA for an established SART-member IVF clinic)

Purchase Price

Approximately $38,000/month on $2.6M bank loan at 9% over 7 years

Monthly Service

Approximately 1.45x on $1M EBITDA after physician compensation normalization and debt service

DSCR

PE equity contribution: $3.25M (50%); conventional bank term loan: $2.6M (40%); seller-financed note: $650K (10%)

Model your own deal structure →

Lender Tips for Fertility Clinic Acquisitions

1Lead with SART success rate data and CDC ART outcome reports in your lender package — above-average outcomes are the single strongest quality signal for healthcare lenders underwriting fertility clinic acquisitions.
2Demonstrate multi-physician staffing or a signed associate RE employment agreement before approaching lenders; key-man concentration in a single reproductive endocrinologist is the top reason healthcare lenders decline or restructure fertility clinic deals.
3Present a normalized QoE report that adjusts for above-market founder compensation, one-time embryology equipment purchases, and owner-paid personal expenses to accurately represent true clinic EBITDA for debt sizing.
4Prepare a detailed IVF laboratory equipment schedule with age, maintenance history, and replacement cost estimates; lenders will escrow capital reserves for lab capex if documentation is incomplete or equipment exceeds useful life.

Frequently Asked Questions

Can I use an SBA loan to acquire a fertility clinic?

No. Fertility clinics structured under MSO or professional corporation models are generally ineligible for SBA 7(a) financing due to passive income rules and corporate practice of medicine restrictions. Conventional healthcare lenders are the standard path.

What EBITDA multiple should I expect to pay for an IVF clinic?

Established SART-member fertility clinics with $1.5M+ EBITDA typically trade at 5x–9x EBITDA. Clinics with above-average success rates, multiple REs, and employer benefit contracts command the upper end of that range.

How does an MSO structure affect financing for a fertility clinic acquisition?

An MSO separates management and clinical operations to comply with corporate practice of medicine laws. Lenders finance the MSO entity; the clinical PC holds the physician contracts. Lenders require clear inter-entity agreements and cash flow assignment to the MSO.

What post-close capital should I budget beyond the purchase price?

Budget $500K–$1.5M for IVF laboratory equipment upgrades, CLIA and SART accreditation maintenance, EHR integration, and working capital during the physician transition period, which typically spans 12–18 months post-close.

More Fertility Clinic Guides

Buy a Fertility Clinic Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Fertility Clinic acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required